Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...

The QIDP status, granted by USFDA makes VRP-034 eligible for regulatory benefits including priority FDA review, potential ...

Light-activated copper microrobots use single-atom catalysis and peroxide to penetrate biofilms, generate reactive oxygen ...

Venus Remedies’ novel polymyxin B formulation, VRP-034 gets US FDA QIDP designation: Our Bureau, Bengaluru Thursday, April 17, 2025, 12:15 Hrs [IST] Venus Remedies’ investigat ...

Scientists at Roche and Harvard University have discovered an entirely new class of antibiotic that can kill a highly drug-resistant ... class of drug to treat Gram-negative bacterial infections ...

Doripenem, a member of the β-lactam class of antibiotics ... bactericidal activity against gram-positive bacteria; enteric and nonenteric gram-negative bacteria, including extended-spectrum ...

The Venus Remedies investigational product, VRP-034, has been granted QIDP designation by the US FDA for the treatment of bloodstream infections caused by polymyxin B (PMB)-susceptible strains in adul ...

The human immune system is highly complex and well-equipped to combat most bacteria. However, in some instances bacteria can cause life-threatening infections and the increase of antibiotic-resistant ...

The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a ...

Could a gene regulatory network in gut microbes have evolved its elaborate and tightly regulated molecular machinery only to pump out antibiotics indiscriminately? Researchers show this is an ...

Gepotidacin, an antibiotic currently used to treat urinary tract infections, could be a new treatment to treat gonorrhea, ...